Mr Thomas Hamborg

Profile

I am a senior lecturer in medical statistics primarily working as a senior statistician on Pragmatic Clinical Trials Unit supported trials. I am also an expert statistics adviser for the Imperial Hub of the NIHR Research Support Service (RSS) and a member of the NIHR/RfPB London funding panel.

I have a background in medical statistics, hold a first degree in Mathematics and have over a decade of experience working in an academic clinical trials environment.

Research

Research Interests:

I’m interested in novel methods for the design, conduct and analysis of RCTs as well as the use of routine data in trials.

Research Groups:

• Pragmatic Clinical Trials Unit
• NIHR Research Support Service

Publications

• Hart A, Miller L, Büttner FC et al. . Fatigue, pain and faecal incontinence in adult inflammatory bowel disease patients and the unmet need: a national cross-sectional survey.

  
  

  DOI: 10.1186/s12876-024-03570-8

  
  

  QMRO:
• Stagg I, Hart A, Cléirigh Büttner F et al. (2024). Optimising fatigue, abdominal pain and faecal incontinence in people with inflammatory bowel disease (IBD-BOOST Optimise): feasibility study of a checklist and algorithm for initial nurse-led management.

  
  

  DOI: 10.1136/bmjgast-2024-001585

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/103288
• Pearse R, Hamborg T (2024). Cardiac output-guided haemodynamic therapy for patients undergoing major gastrointestinal surgery: the OPTIMISE II randomised clinical trial..

  
  

  DOI: 10.1136/bmj-2024-080439

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100265
• Roukas C, Miller L, Büttner FC et al. (2024). Impact of pain, fatigue and bowel incontinence on the quality of life of people living with inflammatory bowel disease: A UK cross‐sectional survey.

  
  

  DOI: 10.1002/ueg2.12668

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/98596
• Norton C, Moss-Morris R, Hart A et al. (2024). O28 IBD-BOOST, a digital cognitive behavioural self-management programme for fatigue, and/or pain, and/or faecal incontinence in IBD: randomised controlled trial. Oral Presentations

  
  

  DOI: 10.1136/gutjnl-2024-bsg.28

  
  

  QMRO:
• Dimascio L, Hamborg T, Mihaylova B et al. (2024). ADHESIVE CAPSULITIS CORTICOSTEROID AND DILATION RANDOMISED CONTROLLED TRIAL: A FEASIBILITY STUDY IN PRIMARY CARE (ACCorD)..

  
  

  DOI: 10.1302/2633-1462.53.BJO-2023-0114

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/92570
• Di Mascio L, Hamborg T, Mihaylova B et al. . The Adhesive Capsulitis Corticosteroid and Dilation (ACCorD) randomized controlled trial.

  
  

  DOI: 10.1302/2633-1462.53.bjo-2023-0114

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95099
• Toader A-M, Campbell MK, Quint JK et al. . Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage.

  
  

  DOI: 10.1186/s13063-024-07926-z

  
  

  QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/94438
• Norton C, Morris RM, Hart A et al. (2024). P651 A randomised controlled trial of IBD-BOOST, a digital cognitive behavioural self-management programme for fatigue, and/or pain, and/or faecal incontinence in inflammatory bowel disease.

  
  

  DOI: 10.1093/ecco-jcc/jjad212.0781

  
  

  QMRO:
• Norton C, Hart A, Miller L et al. (2023). P106 The relationship between fatigue, pain and urgency in 8486 people with inflammatory bowel disease: a survey. Poster presentations

  
  

  DOI: 10.1136/gutjnl-2023-bsg.178

  
  

  QMRO: